Skip to main content
The Egyptian Journal of Internal Medicine
Download PDF
  • Original article
  • Open access
  • Published:

Thyroid dysfunction in obese adults in relation to nonalcoholic fatty liver disease

The Egyptian Journal of Internal Medicine volume 31, pages 629–634 (2019)Cite this article

Abstract

Background

Hormones of the thyroid gland play an important role in the regulation of various metabolic processes. Disturbances in thyroid hormone concentrations may lead to hyperlipidemia and obesity, thus contributing to nonalcoholic fatty liver disease (NAFLD).

Aim

To evaluate thyroid dysfunction and determine its possible relationship to NAFLD in obese adults.

Patients and methods

Our cross-sectional study recruited 100 obese patients, who were subjected to full medical history, physical examination, abdominal ultrasonography, and routine laboratory tests in addition to liver function and thyroid function tests. NAFLD was recognized on the basis of ultrasonographic findings, and in the absence of other causes of liver disease.

Results

The patients were divided into two groups: group 1 (65 patients) with NAFLD and group 2 (35 patients) without NAFLD. Out of 100 patients recruited into the study, the most common thyroid dysfunction was overt hypothyroidism (22%), followed by (9%) subclinical hypothyroidism. Twenty-six (40%) patients with NAFLD were found to have thyroid dysfunction, of them eight (12.3%) NAFLD patients had subclinical hypothyroidism, and 18 (27.7%) NAFLD patients had overt hypothyroidism. Although prevalence of thyroid dysfunction (whether overt hypothyroidism or subclinical hypothyroidism) was 22 and 9%, respectively, among patients with obesity, there was nonsignificant positive correlation between BMI and thyroid-stimulating hormone (r=0.051 and P=0.612). Multivariate regression analysis showed that fatty liver, obesity index, and dyslipedemia were predictors of thyroid dysfunction in obese patients.

Conclusion

Thyroid hypofunction is common in obese patients with NAFLD, which has implications for screening for hypothyroidism in patients with NAFLD and for the administration of appropriate therapy for hypothyroidism.

References

  1. Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease. Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 2016; 64:73–84.

    PubMed  Google Scholar 

  2. Loria P, Carulli L, Bertolotti M, Lonardo A. Endocrine and liver interaction: the role of endocrine pathways in NASH. Nature Rev Gastroenterol Hepatol 2009; 6:236–247.

    Article  CAS  Google Scholar 

  3. Michalaki MA, Vagenakis AG, Leonardou AS, Argentou MN, Habeos IG, Makri MG, et al. Thyroid function in humans with morbid obesity. Thyroid 2006; 16:73–78.

    Article  CAS  Google Scholar 

  4. Raftopoulos Y, Gagne DJ, Papasavas P, Hayetian F, Maurer J, Bononi P, et al. Improvement of hypothyroidism after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Obe Surg 2004; 14:509–513.

    Article  Google Scholar 

  5. Mishra P, Younossi ZM. Abdominal ultrasound for diagnosis of nonalcoholic fatty liver disease (NAFLD). Am J Gastroenterol 2007; 102:2716.

    Article  Google Scholar 

  6. World Health Organization. Report of a WHO Consultation on Obesity. Obesity: Preventing and Managing the Global Epidemic. Geneva: World Health Organization; 1998.

    Google Scholar 

  7. Chen Y, Wu X, Wu R, Sun X, Yang B, Wang Yi, Xu Y. Changes in profile of lipids and adipokines in patients with newly diagnosed hypothyroidism and hyperthyroidism Scientific Reports 2016; 6:26174.

    Article  CAS  Google Scholar 

  8. Solanki A, Bansal S, Jindal S, Saxena V, Shukla US. Relationship of serum thyroid stimulating hormone with body mass index in healthy adults. Indian J Endocrinol Metab 2013; 17 (Suppl 1):S167–S169.

    Article  Google Scholar 

  9. Knudsen N, Laurberg P, Rasmussen LB, Bu?low I, Perrild H, Ovesen L, et al. Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population. J Clin Endocrinol Metab 2005; 90:4019–4024.

    Article  CAS  Google Scholar 

  10. Loomis AK, Kabadi S, Preiss D, Hyde C, Bonato V, St Louis M, et al. Body mass index and risk of non-alcoholic fatty liver disease: Two electronic health record prospective studies. J Clin Endocrinol Metab 2016; 101:945–952.

    Article  CAS  Google Scholar 

  11. Ludwig U, Holzner D, Denzer C, Greinert A, Haenle M, Oeztuerk S, et al. Subclinical and clinical hypothyroidism and non-alcoholic fatty liver disease: a cross sectional study of a random population sample aged 18 to 65 years. BMC Endocr Disord 2015; 15:41.

    Article  Google Scholar 

  12. Dimitriadis G, Mitrou P, Lambadiari V, Boutati E, Maratou E, Pangiotakos DB, et al. Insulin action in adipose tissue and muscle in hypothyroidism. J Clin Endocrinol Metab 2006; 91:4930–4937.

    Article  CAS  Google Scholar 

  13. Pucci E, Chiovato L, Pinchera A. Thyroid and lipid metabolism. Int J Obes Relat Metab Disord 2000; 24:S109–S112.

    Article  CAS  Google Scholar 

  14. Shantha GP, Kumar AA, Jeyachandran V, Tajamanickam D, Rajkumar K, Salim S, et al. Association between primary hypothyroidism and metabolic syndrome and the role of C reactive protein: a cross-sectional study from South India. Thyroid Res 2009; 2:2.

    Article  Google Scholar 

  15. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001; 50:1844–1850.

    Article  CAS  Google Scholar 

  16. Chung GE, Kim D, Kim W, Yim JY, Park MJ, Kim YJ, et al. Non-alcoholic fatty liver disease across the spectrum of hypothyroidism. J Hepatol 2012; 57:150–156.

    Article  CAS  Google Scholar 

  17. Bano A, Chaker L, Plompen EP, Hofman A, Dehghan A, Franco OH, et al. Thyroid function and the risk of nonalcoholic fatty liver disease: the Rotterdam Study. J Clin Endocrinol Metab 2016; 101:3204–3211.

    Article  CAS  Google Scholar 

  18. He W, An X, Li L, Shao X, Li Q, Yao Q, et al. Relationship between hypothyroidism and non-alcoholic fatty liver disease: a systematic review and meta-analysis. Front Endocrinol 2017; 8:335.

    Article  Google Scholar 

  19. Lee KW, Bang KB, Rhee EJ, Kwon HJ, Lee MY, Cho YK. Impact of hypothyroidism on the development of non-alcoholic fatty liver disease: a 4-year retrospective cohort study. Clin Mol Hepatol 2015; 21:372.

    Article  Google Scholar 

  20. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Inter Med 2000; 160:526–534.

    Article  CAS  Google Scholar 

  21. Pearce EN. Update in lipid alterations in subclinical hypothyroidism. J Clin Endocrinol Metab 2012; 97:326–333.

    Article  CAS  Google Scholar 

  22. Hueston WJ, Pearson WS. Subclinical hypothyroidism and the risk of hypercholesterolemia. Ann Fam Med 2004; 2:351–355.

    Article  Google Scholar 

  23. Erem C. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity. Clin Endocrinol 2006; 64:323–329.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Assiut Faculty of Medicine, Assiut University, Assiut, 71515, Egypt

    Fatema Abu Bakr Abdel-Moez, Ghada A. Mohamed MD, Wael A. Abbas, Mohamed A. A. Abozaid & Shymaa Mohammed

Authors
  1. Fatema Abu Bakr Abdel-Moez
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ghada A. Mohamed MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Wael A. Abbas
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mohamed A. A. Abozaid
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shymaa Mohammed
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ghada A. Mohamed MD.

Additional information

This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Abdel-Moez, F.A.B., Mohamed, G.A., Abbas, W.A. et al. Thyroid dysfunction in obese adults in relation to nonalcoholic fatty liver disease. Egypt J Intern Med 31, 629–634 (2019). https://doi.org/10.4103/ejim.ejim_15_19

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.4103/ejim.ejim_15_19

Keywords